2014

/Tag:2014

Oramed Pharmaceuticals to Present at the BIO International Convention in San Diego

Company CEO to present on June 26, 2014, at 10:30am (PDT) JERUSALEM, June 23, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its Chief Executive Officer, Nadav Kidron, [...]

2018-05-30T17:04:26+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals to Present at the American Diabetes Association 74th Scientific Sessions on June 13 – 17, 2014 in San Francisco

JERUSALEM, June 10, 2014 /PRNewswire/ --   Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that three scientific abstracts summarizing studies performed with ORMD-0801, its orally ingestible insulin capsule, were accepted for [...]

2018-05-30T17:04:26+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Added to the Morgan Stanley Capital International (MSCI) MicroCap Index

JERUSALEM, May 29, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has been added to the Morgan Stanley Capital International (MSCI) MicroCap Index, effective as of market [...]

2018-05-30T17:04:27+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Jefferies Global Healthcare Conference on June 2 in New York City

JERUSALEM, May 27, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Nadav Kidron, the Company's Chief Executive Officer, will deliver a corporate presentation at the Jefferies Global Healthcare Conference [...]

2018-05-30T17:04:27+00:00 Categories: Press Releases|Tags: |

Oramed to Present Poster on its Oral Insulin Capsule at the Yale Diabetes Symposium

JERUSALEM, May 13, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that a poster on the Company's orally ingestible insulin capsule, ORMD-0801, will be presented at the Yale Diabetes [...]

2018-05-30T17:04:27+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 in Type 2 Diabetes at the 2014 Diabetes Summit

ORMD-0801 Oral Insulin Appeared Safe and Well-tolerated. No Hypoglycemic Events or Treatment Related Adverse Events Observed JERUSALEM, April 24, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today detailed results [...]

2018-05-30T17:04:27+00:00 Categories: Press Releases|Tags: |

Oramed Granted Patent in Hong Kong for Oral Administration of Insulin

JERUSALEM, April 10, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Intellectual Property Department of Hong Kong has granted the Company's patent for its invention, titled "Methods and [...]

2018-05-30T17:04:28+00:00 Categories: Press Releases|Tags: |

Oramed Granted its 3rd Patent in Australia for Oral Administration of Exenatide

JERUSALEM, March 11, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that IP Australia, the Australian government's patent office, has issued the Company its third patent in the country. The patent, [...]

2018-05-30T17:04:28+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Upcoming Conferences

Presentations Scheduled at Barclays Global Healthcare Conference, BioPharma Asia Convention and ROTH Growth Stock Conference in March JERUSALEM, March 6, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the [...]

2018-05-30T17:04:28+00:00 Categories: Press Releases|Tags: |